Feryskol 210 Tablet contains Ferric Citrate 210 mg, a highly bioavailable iron salt and phosphate binder, widely used in iron deficiency anemia and chronic kidney disease (CKD) patients requiring phosphate management.
This tablet works by supplying elemental iron to replenish iron stores while binding dietary phosphate, helping maintain optimal mineral balance in CKD patients. It ensures improved hemoglobin levels and reduced phosphate burden, making it an effective choice for both renal and hematology clinical protocols.
Clinically, Feryskol 210 Tablet is used in patients with chronic kidney disease on dialysis, iron deficiency anemia, or related conditions, where careful monitoring of iron and phosphate levels is critical for safety and efficacy.
The tablet provides consistent dosing, high absorption, and reliable therapeutic outcomes, making it suitable for hospitals, nephrology clinics, dialysis centers, and specialty pharmacies that require a dependable iron supplement and phosphate management therapy.